RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
  Anorexia Nervosa
  Anxiety
  Bulimia
  CFS
  Child Psychiatry
  Depression
  Forensic Psychiatry
  Learning-Disabilities
  Mood Disorders
  Neuropsychiatry
  Peri-Natal Psychiatry
  Personality Disorders
  Psychology
  Psychoses
  Psychotherapy
  Sleep Disorders
  Substance Abuse
   Alcohol
   Amphetamine
   Cannabis
   Cocaine
   Opiates
   Smoking
  Suicide
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Substance Abuse Channel

subscribe to Substance Abuse newsletter
Latest Research : Psychiatry : Substance Abuse

   EMAIL   |   PRINT
New Medicinal Cannabis Study Published

Mar 17, 2005 - 7:13:00 PM
45 per cent of 916 respondents said cannabis worked better than prescribed medication. 30 per cent of the 872 who answered the question on side effects, said that prescribed drugs were worse than cannabis and 34 per cent said the side effects were much worse

 
[RxPG] Sixteen per cent of people who use cannabis for medical reasons say that their doctor suggested it, according to research published in the March issue of IJCP, the International Journal of Clinical Practice.

947 people in the UK reported using cannabis for medical purposes, with more than a third (35 per cent) saying that they used it six or seven days a week. The majority (68 per cent) said that it made their symptoms much better.

"The results of our UK survey, including the extent of use and reported effects, lend support to the further development of safe and effective medicines based on cannabis" says lead author Dr Mark Ware principal investigator and pain physician at the McGill University Health Centre (MUHC) Pain Centre.

People with chronic pain were most likely to use cannabis for medicinal purposes (25 percent) followed by patients with multiple sclerosis (22 per cent), depression (22 per cent) arthritis (21 per cent) and neuropathy (19 per cent).

Younger people, males and those who had used cannabis recreationally were also more likely to use it for medicinal reasons.

Key findings included:
# 73 per cent of respondents used cannabis at least once a week, with 35 per cent using it six or seven times a week.

# 62 per cent said a friend, family members of acquaintance had suggested it and 55 per cent said they had read a book or article about cannabis. 19 per cent were prior users or had found out its benefits by accident and 16 per cent said their doctor had suggested it.

# The majority of users (82 per cent) smoked the drug. Other methods included eating it (43 per cent) and making cannabis tea (28 per cent).

# 916 reported average usage levels, with the largest percentage (27 per cent) using one to two grams per day. Only two per cent used 10 or more grams a day and seven per cent used five to nine grams a day.

# 45 per cent of 916 respondents said cannabis worked better than prescribed medication. 30 per cent of the 872 who answered the question on side effects, said that prescribed drugs were worse than cannabis and 34 per cent said the side effects were much worse.

# 77 per cent of 876 respondents said their symptoms returned or got worse when they stopped using cannabis.

"To our knowledge this is the most extensive survey of medicinal cannabis use among chronically ill patients conducted to date" says Dr Ware. "We believe that it presents a broad picture of the current state of cannabis use for medicinal purposes in the UK."



Publication: March issue of IJCP, the International Journal of Clinical Practice.
On the web: http://www.mcgill.ca/ 

Advertise in this space for $10 per month. Contact us today.


Related Substance Abuse News
Crystal methamphetamine use by street youth increases risk of injecting drugs
Drivers who test positive for drugs have triple the risk of a fatal car crash
Sex trafficking and exploitation of minors serious problems in the US, says new report
Study reveals why warnings may be ineffective at teaching young people about risks
The skinny on cocaine
82 percent of adults support banning smoking when kids are in the car
New evidence suggests impulsive adolescents more likely to drink heavily
Missing enzyme linked to drug addiction
Addiction to unhealthy foods could help explain the global obesity epidemic
Older people may be at greater risk for alcohol impairment than teens, according to Baylor Study

Subscribe to Substance Abuse Newsletter

Enter your email address:


 Additional information about the news article
The Research Institute of the MUHC is a world world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, a university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 500 researchers, nearly 1000 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge. For further details visit: www.muhc.ca/research.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)